ANA Mª
GONZÁLEZ-PINTO ARRILLAGA
Icahn School of Medicine at Mount Sinai
Nueva York, Estados UnidosIcahn School of Medicine at Mount Sinai-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2024
-
Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders
Biological Psychiatry, Vol. 96, Núm. 5, pp. 376-389
2022
-
Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review
European Neuropsychopharmacology, Vol. 54, pp. 90-99
2021
-
Corrigendum to “Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121–136]” (European Neuropsychopharmacology (2020) 36 (121–136), (S0924977X20301802), (10.1016/j.euroneuro.2020.05.006))
European Neuropsychopharmacology
-
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis – A narrative review from the ECNP bipolar disorders network
European Neuropsychopharmacology, Vol. 47, pp. 54-61
2013
-
The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders
American Journal of Psychiatry, Vol. 170, Núm. 11, pp. 1249-1262